Concepedia

Publication | Open Access

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

DOIFull Paper Access

1.3K

Citations

32

References

2004

Year

John B. Buse, Robert R. Henry, Jenny Han, Dennis Dong Hwan Kim, Mark Fineman, Alain Baron
Diabetes Care

Abstract

Exenatide significantly reduced HbA(1c) in patients with type 2 diabetes failing maximally effective doses of a sulfonylurea. Exenatide was generally well tolerated and was associated with weight loss.

References

YearCitations

Page 1